These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 25005357

  • 1. Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors.
    Foronjy RF, Taggart CC, Dabo AJ, Weldon S, Cummins N, Geraghty P.
    Mucosal Immunol; 2015 Jan; 8(1):161-75. PubMed ID: 25005357
    [Abstract] [Full Text] [Related]

  • 2. Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.
    Foronjy RF, Dabo AJ, Cummins N, Geraghty P.
    BMC Immunol; 2014 Oct 03; 15():41. PubMed ID: 25277705
    [Abstract] [Full Text] [Related]

  • 3. Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.
    Makris S, Bajorek M, Culley FJ, Goritzka M, Johansson C.
    J Innate Immun; 2016 Oct 03; 8(5):452-63. PubMed ID: 27423203
    [Abstract] [Full Text] [Related]

  • 4. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
    Guo X, Liu T, Shi H, Wang J, Ji P, Wang H, Hou Y, Tan RX, Li E.
    J Virol; 2015 Aug 03; 89(15):7636-45. PubMed ID: 25972545
    [Abstract] [Full Text] [Related]

  • 5. Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection.
    Liu T, Zang N, Zhou N, Li W, Xie X, Deng Y, Ren L, Long X, Li S, Zhou L, Zhao X, Tu W, Wang L, Tan B, Liu E.
    J Virol; 2014 Apr 03; 88(8):4229-36. PubMed ID: 24478430
    [Abstract] [Full Text] [Related]

  • 6. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.
    Goritzka M, Makris S, Kausar F, Durant LR, Pereira C, Kumagai Y, Culley FJ, Mack M, Akira S, Johansson C.
    J Exp Med; 2015 May 04; 212(5):699-714. PubMed ID: 25897172
    [Abstract] [Full Text] [Related]

  • 7. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway.
    Liu P, Li K, Garofalo RP, Brasier AR.
    J Biol Chem; 2008 Aug 22; 283(34):23169-78. PubMed ID: 18550535
    [Abstract] [Full Text] [Related]

  • 8. T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R.
    Goritzka M, Pereira C, Makris S, Durant LR, Johansson C.
    Sci Rep; 2015 Dec 21; 5():18533. PubMed ID: 26688048
    [Abstract] [Full Text] [Related]

  • 9. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus.
    Bhoj VG, Sun Q, Bhoj EJ, Somers C, Chen X, Torres JP, Mejias A, Gomez AM, Jafri H, Ramilo O, Chen ZJ.
    Proc Natl Acad Sci U S A; 2008 Sep 16; 105(37):14046-51. PubMed ID: 18780793
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.
    Zang N, Xie X, Deng Y, Wu S, Wang L, Peng C, Li S, Ni K, Luo Y, Liu E.
    J Virol; 2011 Dec 16; 85(24):13061-8. PubMed ID: 21937650
    [Abstract] [Full Text] [Related]

  • 11. Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection.
    Boyapalle S, Wong T, Garay J, Teng M, San Juan-Vergara H, Mohapatra S, Mohapatra S.
    PLoS One; 2012 Dec 16; 7(2):e29386. PubMed ID: 22383950
    [Abstract] [Full Text] [Related]

  • 12. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice.
    Long X, Li S, Xie J, Li W, Zang N, Ren L, Deng Y, Xie X, Wang L, Fu Z, Liu E.
    Respir Res; 2015 Feb 05; 16(1):11. PubMed ID: 25652021
    [Abstract] [Full Text] [Related]

  • 13. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H, Honda K, Atarashi K, Kobayashi F, Ebihara T, Oshiumi H, Matsumoto M, Shingai M, Seya T.
    Mol Immunol; 2014 Feb 05; 57(2):100-10. PubMed ID: 24096085
    [Abstract] [Full Text] [Related]

  • 14. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.
    Lifland AW, Jung J, Alonas E, Zurla C, Crowe JE, Santangelo PJ.
    J Virol; 2012 Aug 05; 86(15):8245-58. PubMed ID: 22623778
    [Abstract] [Full Text] [Related]

  • 15. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
    Pythoud C, Rothenberger S, Martínez-Sobrido L, de la Torre JC, Kunz S.
    J Virol; 2015 Jun 05; 89(12):6240-50. PubMed ID: 25833049
    [Abstract] [Full Text] [Related]

  • 16. Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection.
    Varese A, Nakawesi J, Farias A, Kirsebom FCM, Paulsen M, Nuriev R, Johansson C.
    PLoS Pathog; 2022 Feb 05; 18(2):e1010272. PubMed ID: 35108347
    [Abstract] [Full Text] [Related]

  • 17. Neutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection.
    Kirsebom FCM, Kausar F, Nuriev R, Makris S, Johansson C.
    Mucosal Immunol; 2019 Sep 05; 12(5):1244-1255. PubMed ID: 31358860
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.
    Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, Brasier AR.
    J Virol; 2007 Feb 05; 81(3):1401-11. PubMed ID: 17108032
    [Abstract] [Full Text] [Related]

  • 19. The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.
    Webster Marketon JI, Corry J, Teng MN.
    Virology; 2014 Jan 20; 449():62-9. PubMed ID: 24418538
    [Abstract] [Full Text] [Related]

  • 20. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection.
    Lee HC, Headley MB, Loo YM, Berlin A, Gale M, Debley JS, Lukacs NW, Ziegler SF.
    J Allergy Clin Immunol; 2012 Nov 20; 130(5):1187-1196.e5. PubMed ID: 22981788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.